CordovaCann (LVRLF) Shares Outstanding (Weighted Average) (2009 - 2025)
CordovaCann (LVRLF) recorded quarterly Shares Outstanding (Weighted Average) of $22.1 million in Q2 2025, down 0.94% quarter-over-quarter from $22.3 million in Q2 2024, and down 0.94% on a YoY basis from $22.3 million in Q2 2024.
CordovaCann (LVRLF) Shares Outstanding (Weighted Average) (2009 - 2025) Analysis & Trends
CordovaCann's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $22.1 million for Q2 2025.
- In Q2 2025, Shares Outstanding (Weighted Average) fell 0.94% year-over-year to $22.1 million; the TTM figure through Jun 2025 stood at $22.1 million (down 0.94% YoY), while the FY2025 annual figure was $21.9 million, down 2.55% from the prior year.
- Shares Outstanding (Weighted Average) was $22.1 million for Q2 2025 at CordovaCann, down from $22.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $23.9 million in Q2 2022 to a low of $21.3 million in Q2 2021.
- Historically, Shares Outstanding (Weighted Average) has averaged $22.4 million across 5 years, with a median of $22.3 million in 2024.
- The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Weighted Average) soared 49.73% in 2021, then dropped 5.09% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $21.3 million in 2021, then increased by 12.38% to $23.9 million in 2022, then slipped by 5.09% to $22.7 million in 2023, then dropped by 1.79% to $22.3 million in 2024, then dropped by 0.94% to $22.1 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $22.1 million (Q2 2025), $22.3 million (Q2 2024), and $22.7 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | CordovaCann | - | - | - | 22.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 22.07 Mn |
| Jun 30, 2024 | 22.28 Mn |
| Jun 30, 2023 | 22.69 Mn |
| Jun 30, 2022 | 23.90 Mn |
| Jun 30, 2021 | 21.27 Mn |
| Jun 30, 2020 | 14.21 Mn |
| Mar 31, 2020 | 11.12 Mn |
| Dec 31, 2019 | 11.09 Mn |
| Sep 30, 2019 | 11.09 Mn |
| Jun 30, 2019 | 30.48 Mn |
| Mar 31, 2019 | 10.89 Mn |
| Dec 31, 2018 | 10.97 Mn |
| Sep 30, 2018 | 11.08 Mn |
| Jun 30, 2018 | 31.03 Mn |
| Mar 31, 2018 | 109.19 |
| Dec 31, 2017 | 7.24 Mn |
| Sep 30, 2017 | 0.80 |
| Jun 30, 2017 | 17.49 Mn |
| Mar 31, 2017 | 2.27 |
| Dec 31, 2016 | 1.50 |